$0.9601
0.021.69%
At close: -
$0.9897
0.033.08%
After Hours: 6:09 PM EDT
Atossa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atossa Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.06 | $-0.06 | 0.00 % |
Q2 | 2024-08-12 | $-0.05 | $-0.06 | 16.7 % |
Q1 | 2024-05-13 | $-0.05 | $-0.07 | 28.6 % |
Q4 | 2024-04-01 | $-0.06 | $-0.05 | -20.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Atossa Therapeutics (ATOS) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.06, which hit the estimate of $-0.06.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.